Gadolinium Injuries

In recent years, numerous reports have surfaced linking gadolinium to nephrogenic systemic fibrosis and other serious gadolinium side effects and injuries. Since 2006, the Food and Drug Administration has issued several warnings regarding the risks associated with gadolinium-based MRI dyes, including in June 2006, December 2006, and May 2007. Most recently, the FDA urged makers of gadolinium-based contrast agents to include a black box on the product labeling to warn of the risk of injury and nephrogenic systemic fibrosis.

What is Gadolinium?

Gadolinium is used as a contrast agent in MRI (magnetic resonance imaging) dyes and is injected into a patient to create a sharper image of the body’s internal structures. What many patients do not know is that gadolinium is a heavy metal toxin—occurring naturally in the earth but not in the human body.

Patients with healthy kidneys are able to rapidly flush the gadolinium from their bodies. However, patients with kidney disease or kidney deficiencies are unable to efficiently flush the gadolinium from their bodies, and the prolonged exposure to the substance makes these patients more likely to suffer a gadolinium injury.

What is Nephrogenic Systemic Fibrosis?

The most serious injury gadolinium has been linked to is nephrogenic systemic fibrosis, which is an extremely rare disease that affects the skin, muscles, and internal organs. Patients who develop nephrogenic systemic fibrosis suffer from a tightening and hardening of these areas of the body that may result in limited mobility, joint contractures, and bone pain, among other things. In the worst cases, the hardening can affect the diaphragm and other internal structures, making it difficult for the body to function properly. According to the FDA, patients have died as a result of complications related to nephrogenic systemic fibrosis.

NSF is a relatively new disease, and medical experts have yet to discover a consistently effective treatment.

Other Gadolinium Injuries and Side Effects

In addition to nephrogenic systemic fibrosis, other injuries and side effects associated with gadolinium exposure include:

  • Headaches
  • Blood clots
  • Allergic reactions such as hives and facial swelling
  • Inflammation/irritation of superficial blood vessels
  • Nausea
  • Low blood pressure
  • Lightheadedness

Contact An Attorney

If you received a gadolinium-based dye prior to an MRI and subsequently suffered serious injury such as nephrogenic systemic fibrosis, experienced gadolinium attorneys can help you determine the best course of action. Contact a gadolinium attorney today to learn more about your legal rights—free of charge.

Enter Content Here

Gadolinium Contrast Agents Required to Include New Warning

The U.S. Food and Drug Administration (FDA) issued a news release Sept. 9, 2010, requiring that contrast agents containing gadolinium carry a new warning on their labels because it can lead to nephrogenic systemic fibrosis (NSF). Read More »

First Gadolinium Lawsuit Filed in U.S. Court

An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Read More »

Gadolinium-Based MRI Dyes Get Black Box Warning

The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
Read More »